Cerity Partners LLC Buys 12,107 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Cerity Partners LLC lifted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 25.4% in the 4th quarter, HoldingsChannel reports. The fund owned 59,767 shares of the financial services provider’s stock after purchasing an additional 12,107 shares during the quarter. Cerity Partners LLC’s holdings in iShares Biotechnology ETF were worth $8,119,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the stock. Moneta Group Investment Advisors LLC increased its position in iShares Biotechnology ETF by 131,598.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 4,469,845 shares of the financial services provider’s stock valued at $586,846,000 after buying an additional 4,466,451 shares in the last quarter. JPMorgan Chase & Co. increased its position in iShares Biotechnology ETF by 159.9% during the 1st quarter. JPMorgan Chase & Co. now owns 1,966,359 shares of the financial services provider’s stock valued at $253,975,000 after buying an additional 1,209,700 shares in the last quarter. Goldman Sachs Group Inc. increased its position in iShares Biotechnology ETF by 49.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,568,159 shares of the financial services provider’s stock valued at $204,332,000 after buying an additional 521,820 shares in the last quarter. Jane Street Group LLC increased its position in iShares Biotechnology ETF by 5.4% during the 4th quarter. Jane Street Group LLC now owns 1,002,554 shares of the financial services provider’s stock valued at $131,625,000 after buying an additional 50,999 shares in the last quarter. Finally, International Assets Investment Management LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter valued at about $76,425,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 1.3 %

Shares of NASDAQ:IBB opened at $127.84 on Tuesday. The business’s 50-day moving average is $135.82 and its 200 day moving average is $129.54. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were given a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a yield of 0.39%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.